Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motavizumab vs Palivizumab in Children with Congenital Heart Disease
NCT00538785Phase 2Completed
- Sponsor
- MedImmune
- Start
- Oct 2005
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 17
01
Overview
A Phase 2 trial of motavizumab in respiratory syncytial virus infection (RSV), sponsored by MedImmune. Started Oct 2005; status: completed.
02
Drugs
motavizumab
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT00538785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00538785.